ARCHIVES

DeVita Accepts “Chop Lie” Cancer Control Elements In CCOP; RFA Delays Until After May NCAB Meeting

This article is from The Cancer Letter archive.

Vol. 08 No. 11 | March 12, 1982

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

June 25, 2004

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

NCI Bypass Budget For FY 1992 Requests $2.6 Billion Support grows In Congress

May 18, 1990

Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’

August 9, 1991

Institute of Medicine Elects 80 New Members

October 24, 2014

June Panel Meeting Dropped

June 3, 1977